BRTE yields 2000000.00% · JNJ yields 2.14%● Live data
📍 BRTE pulled ahead of the other in Year 1
Combined, BRTE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BRTE + JNJ for your $10,000?
Brightec, Inc. engages in the development and marketing of luminescent films incorporating luminescent or phosphorescent pigments in the United States. These pigments absorb and re-emit visible light producing a glow. The company markets and sells films and consumer products, which incorporate luminescent or phosphorescent pigments and are based on its proprietary and patented technology that enables prints to be of photographic quality by day and luminescent under low light or night conditions. It offers various types of glow-in-the-dark films in sheets and rolls for commercial and digital printing needs of the graphic industry, and office and photographic digital printing market; and consumer products, including children puzzles and children stickers under the brand name PlayGlo. The company sells its luminescent product primarily as a printable luminescent film designed to add luminescence to existing and new products. It offers its product through its online store. The company was formerly known as Advanced Lumitech, Inc. and changed its name to Brightec, Inc. in October 2006. Brightec, Inc. was founded in 1992 and is based in Natick, Massachusetts.
Full BRTE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.